Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice. - Wikidata - wikimedia - TriplyDB

Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice.

Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice.

http://www.wikidata.org/entity/Q47214457

about

Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma Role of receptor for advanced glycation end products (RAGE) in liver disease Soluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 Mice.The HMGB1-RAGE Inflammatory Pathway: Implications for Brain Injury-Induced Pulmonary Dysfunction Blocking the Interactions between Calcium-Bound S100A12 Protein and the V Domain of RAGE Using Tranilast Receptor for advanced glycation end products is detrimental during influenza A virus pneumonia.Acute hyperglycemic exacerbation of lung ischemia-reperfusion injury is mediated by receptor for advanced glycation end-products signaling.Increased KIT inhibition enhances therapeutic efficacy in gastrointestinal stromal tumor CB2 receptor activation ameliorates the proinflammatory activity in acute lung injury induced by paraquat.Molecular Pathways Involved in the Amelioration of Myocardial Injury in Diabetic Rats by Kaempferol.Lack of the receptor for advanced glycation end-products attenuates E. coli pneumonia in mice Ringer's lactate improves liver recovery in a murine model of acetaminophen toxicity.Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death.Clearance kinetics and matrix binding partners of the receptor for advanced glycation end products.Apoptotic response through a high mobility box 1 protein-dependent mechanism in LPS/GalN-induced mouse liver failure and glycyrrhizin-mediated inhibition.Remote ischemic preconditioning protects against liver ischemia-reperfusion injury via heme oxygenase-1-induced autophagy Overexpression of the Receptor for Advanced Glycation Endproducts (RAGE) is associated with poor prognosis in gastric cancer.Isolevuglandin-type lipid aldehydes induce the inflammatory response of macrophages by modifying phosphatidylethanolamines and activating the receptor for advanced glycation endproducts.Ligands of the receptor for advanced glycation end products, including high-mobility group box 1, limit bacterial dissemination during Escherichia coli peritonitis.The HMGB1 receptor RAGE mediates ischemic brain damage.The Receptor for Advanced Glycation Endproducts Does Not Contribute to Pathology in a Mouse Mesenteric Ischemia/Reperfusion-Induced Injury Model.The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion.Macrophage activation by factors released from acetaminophen-injured hepatocytes: potential role of HMGB1 Interaction of β1-adrenoceptor with RAGE mediates cardiomyopathy via CaMKII signaling.Imaging of receptors for advanced glycation end products in experimental myocardial ischemia and reperfusion injury Soluble receptor for advanced glycation end products and risk of liver cancer.The Receptor for Advanced Glycation End Products Activates the AIM2 Inflammasome in Acute Pancreatitis.Advanced glycation and lipoxidation end products--amplifiers of inflammation: the role of food.Reactive metabolites and AGE-RAGE-mediated inflammation in patients following liver transplantation Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure.Bench-to-bedside review: The inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis.Prolonged treatment with N-acetylcystine delays liver recovery from acetaminophen hepatotoxicity.Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease.Characterization of RAGE, HMGB1, and S100beta in inflammation-induced preterm birth and fetal tissue injury.Losartan protects liver against ischaemia/reperfusion injury through PPAR-γ activation and receptor for advanced glycation end-products down-regulation.KIT oncogene inhibition drives intratumoral macrophage M2 polarization.The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease.Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction.Tempering the wrath of RAGE: an emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation

P2860

Q26781477-323C01F5-BDC0-44C6-ABCD-DE8C7F73475B Q27010462-234CF936-9E30-4FC3-9870-FF3385B8682A Q27319831-46BAC6E8-4108-4AD2-B6FF-295578046E8E Q28085089-5A12F5F1-89CF-4D32-8C71-41F3ADBC0893 Q28553904-6223D062-EA98-40F9-B109-D3301A1B4DC1 Q30378823-21953DD6-AAF3-4689-A6D8-BC60FFB602D8 Q30422075-13EAC793-85EF-4361-B543-DB6E5C0553EF Q33560776-8AE6CD3E-749A-434C-89FE-38D398BBEC09 Q33745557-74CD64BB-EFDC-406B-808E-AF7AB2E68267 Q33755103-3F8A7B6B-FB6A-4A9D-9212-5A24D5742C9D Q33918403-83BE6688-84D2-4638-AB2F-8AC30D0FB564 Q34074958-7EDF1F3C-9475-4F32-A036-2C949EC9841C Q34728267-E29B8470-2EB9-425E-88E4-8BBAE2DD10EE Q34851941-C1D7244A-C264-4C0E-8F0E-EF567F2502FE Q35124150-E8A2582B-9C97-4036-814F-ED1BFE1F86C0 Q35137417-295B92FD-BD79-48EC-B8BC-0F4EEFC446A4 Q35184610-E8E26A46-87FA-4CD6-8A29-F64D08BAE14F Q35364536-E5504474-011B-4251-B210-F6C159DBF865 Q35797182-C72F979D-51B7-4C5E-8735-ED8E86256A60 Q35944988-3814DB73-7196-40F1-BA56-09F12FE97099 Q36134557-87CB1D93-3F1E-4B14-A692-E3FEB4E2E901 Q36349738-22835FD9-94B4-454A-A81B-97E97C9BC9A9 Q36403403-72ECCE28-D4CB-40F1-8744-015DFDFC8FCC Q36426198-B2543EDF-BC8C-4A57-B0A1-6239F82DC763 Q36661845-B895A9FA-B326-43E7-848A-59ACE37CCF95 Q36795745-2ECC444D-093E-44C6-B609-D0FBCA86CE63 Q36816945-F65C7C78-2EA4-494A-BA12-EED858D5C53C Q36905963-F16A9AAE-0200-4037-87AA-4A664745CF23 Q36915810-F1167C79-CB84-4517-94FA-294E0CC0194A Q36916192-C434B6AC-6100-4229-B465-929C593B0C5F Q37066630-B2194A90-C9CD-4C57-B05E-7CB1E8658D49 Q37069537-7B0A8F77-F232-46C7-B053-749600A08463 Q37210142-BD722674-DD4A-4A10-A956-690B53A0C14D Q37267277-486367FB-1BF3-4AE3-B76D-5F8907C85F54 Q37316463-42E8FA8C-D5CA-4E23-AE3F-7F60C5663149 Q37318895-E8296A82-7C4A-47A7-B503-DD70E5D4EA21 Q37397817-E809DB8A-DC87-4A9F-8E59-C73203341E5F Q37412673-336DDA70-6CDB-4C5A-9BD0-F26CE4D8481C Q37423137-5408155C-7782-4E26-82F1-140408A9696C Q37424029-FAE464A4-C6F2-4061-B93F-AB40CA4FBD61

P2860

Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice.

http://www.wikidata.org/entity/Q47214457

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Blockade of receptor for advan ...... n injury to the liver in mice.

@en

Blockade of receptor for advanced glycation end product

@nl

type

label

Blockade of receptor for advan ...... n injury to the liver in mice.

@en

Blockade of receptor for advanced glycation end product

@nl

prefLabel

Blockade of receptor for advan ...... n injury to the liver in mice.

@en

Blockade of receptor for advanced glycation end product

@nl

P1433

Q47214457-8235698F-5728-4D93-B736-3D1111AF21FE

P1476

Q47214457-B7FE1305-9453-4319-93D9-F632593411D5

P2093

Q47214457-01EE9471-DAFA-4E7C-962C-3E63B22AE116

Q47214457-41C33516-B9FB-4228-B729-3F4812DE425A

Q47214457-422EAFD8-27C4-4866-A9A1-45219AFFFB3B

Q47214457-483AA838-9640-4764-9BA5-1B9E3359A874

Q47214457-54352A1D-9BBB-41E0-9D49-3FD75FE38A65

Q47214457-625BFCE5-7347-48A9-ADEE-754DFBB9D24C

Q47214457-779A8BB2-D576-4091-B8A5-ED24749CE049

Q47214457-92809A1A-1158-41BF-8ABF-CFD990098115

Q47214457-DA8494B5-E01C-4655-A240-C6D4B918C733

Q47214457-FCB4DF71-3B07-4E19-A223-3529CD28AE3B

P2860

Q47214457-22711EBD-43F6-49C6-80B3-62E80E981EF7

Q47214457-7FFE343F-1EBF-4CB8-90F6-F106AB3E43B0

P304

Q47214457-24D8F515-2C7B-428A-AF25-8A5E1E75F017

P31

Q47214457-EC7B4286-B393-46E0-9DAC-85D0B07A0AF1

P356

Q47214457-6A5F168A-8362-4521-99F1-318A3D76A644

P407

Q47214457-090E9D79-75C7-4386-9C56-36317D874A4A

P433

Q47214457-121B7058-1811-4E99-9295-7BED105B8182

P478

Q47214457-28F93B46-5240-4B3A-80D9-947982C88391

P577

Q47214457-B4360417-6DE1-48AF-A5B2-379D19E289B3

P5875

Q47214457-8279E3EF-ED17-459F-AC6C-63415C6138EE

P698

Q47214457-7224D571-44AE-4950-8BA3-908AD8FAD935

P921

Q47214457-18F2FF86-C4BB-4188-AB13-D6ADB7D89F9F

P356

P1433

P1476

Blockade of receptor for advan ...... n injury to the liver in mice.

@en

P2093

Ann Marie Schmidt

http://www.w3.org/2001/XMLSchema#string

Hao Dun

http://www.w3.org/2001/XMLSchema#string

James Guarrera

http://www.w3.org/2001/XMLSchema#string

Jean C Emond

http://www.w3.org/2001/XMLSchema#string

Michael Goldstein

http://www.w3.org/2001/XMLSchema#string

Nikalesh Ippagunta

http://www.w3.org/2001/XMLSchema#string

Nikki Feirt

http://www.w3.org/2001/XMLSchema#string

Shan Zeng

http://www.w3.org/2001/XMLSchema#string

Udeme Ekong

http://www.w3.org/2001/XMLSchema#string

Wu Qu

http://www.w3.org/2001/XMLSchema#string

P2860

Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells

Regulation of liver inflammatory injury by signal transducer and activator of transcription-6.

P304

422-432

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.20045

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P577

2004-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8881825

http://www.w3.org/2001/XMLSchema#string

P698

14767995

http://www.w3.org/2001/XMLSchema#string

P921

reperfusion injury